Modeling tracer kinetics in dynamic Gd-DTPA MR imaging

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 1, 1997, Pages 91-101

  Tofts, Paul S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dynamic MRI; Extravascular extracellular space; Gd DTPA; Permeability; Rate constant; Tracer kinetics

Indexed keywords

GADOLINIUM PENTETATE;

BLOOD BRAIN BARRIER; CAPILLARY FLOW; CAPILLARY LEAK SYNDROME; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EXTRACELLULAR SPACE; MATHEMATICAL MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PERMEABILITY; PLASMA CLEARANCE; PRIORITY JOURNAL; REVIEW;

ANIMALS; CONTRAST MEDIA; EXTRACELLULAR SPACE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; PERMEABILITY; RADIOACTIVE TRACERS; REPRODUCIBILITY OF RESULTS;

EID: 0031404162     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070113     Document Type: Review

References (59)

1. van Hecke P, Marchal G, Bosmans H, et al. NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat. Magn Reson Imaging 1991; 9:313-321.
2. Shames DM, Kuwatsuru R, Vexler V, Muhler A, Brasch R Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative noninvasive technique. Magn Reson Med 1993; 29:616-622.
3. Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5T. Radiology 1990; 176:211-220.
4. Hacklander T, Reichenbach JR, Hofer M, Modder U. Measurement of cerebral blood volume via the relaxing effect of low-dose gadopentetate dimeglumine during bolus transit. AJNR Am J Neuroradiol 1996; 17:821-830.
5. Fenstermacher JD, Blasberg RG, Patlak CS. Methods for quantifying the transport of drugs across brain barrier systems. Pharmacol Ther 1981; 14:217-248.
6. Pappenheimer JR. Passage of molecules through capillary walls. Physiol Rev 1953; 33:387-423.
7. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959; 197: 1205-1210.
8. Crone C. The permeability of capillaries in various organs as determined by use of the 'indicator diffusion' method. Acta Physiol Scand 1963; 58:292-305.
9. Ohno K, Pettigrew KD, Rapoport SI. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 1978; 235:H299-307.
10. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3:1-7.
11. Kenny J, Schmiedl U, Maravilla K, Starr F, Graham M, Spence A, Nelson J. Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA. Magn Reson Med 1992; 27:68-75.
12. Schmiedl U, Kenny J, Maravilla K. Kinetics of pathologic blood-brain barrier permeability in a astrocytic glioma using contrast-enhanced MR. AJNR Am J Neuroradiol 1992; 13:5-14.
13. Krueck WG, Schmiedl UP, Maravilla KR, Spence AM, Starr FL, Kenny J. MR assessment of radiation-induced blood-brain barrier permeability changes in a rat glioma model. AJNR Am J Neuroradiol 1994; 15:625-632.
14. Iannotti F, Fieschi C, Alfano B, et al. Simplified, noninvasive PET measurement of blood-brain barrier permeability. J Comput Assist Tomogr 1987; 11:390-397.
15. Ott RJ, Brada M, Flower MA, Babich JW, Cherry SR, Deehan BJ. Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 1991; 27:1356-1361.
16. 68Ga"DTPA and positron computed tomography. J Cereb Blood Flow Metab 1984; 4:507-515.
17. Yeung WTI, Lee TY, Del Maestro RF, Kozak R Brown T. In vivo CT measurement of blood-brain transfer constant of iopamidol in human brain tumors. J Neurooncol 1992; 14:177-187.
18. Donahue KM, Weisskoff RM, Parmelee DJ, Callahan RJ, Wilkinson RA, Mandeville JB, Rosen BR. Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction. Magn Reson Med 1995; 34:423-432.
19. Schwickert HC, Roberts TPL, Shames DM, et al. Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995; 34:845-852.
20. Yoshida K, Furuse M, Kaneoke Y, et al. Assessment of T1 time course changes and tissue-blood ratios after Gd-DTPA administration in brain tumors. Magn Reson Imaging 1989; 7:9-15.
21. Tofts PS, Kermode AG. Measurement of blood brain permeability using Gd-DTPA scanning. Magn Reson Imaging 1989; 7: 150.
22. Tofts PS, Kermode AG. Blood brain permeability measured in multiple sclerosis using labelled DTPA with PET, CT and MRI. J Neurol Neurosurg Psychiatry 1989; 52:1019-1020.
23. Tofts PS, Kermode AG, Barker G. Measurement of the blood-brain permeability using dynamic Gd-DTPA scanning. In: Proceedings of the 8th annual meeting of the Society of Magnetic Resonance in Medicine. Amsterdam: Society of Magnetic Resonance in Medicine, 1989; 805.
24. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect using MRI and gadolinium-DTPA in acute multiple sclerosis. In: Proceedings of the 8th annual meeting of the Society of Magnetic Resonance in Medicine. Amsterdam: Society of Magnetic Resonance in Medicine, 1989; 744.
25. Larsson HBW, Tofts PS. Measurement of blood brain barrier permeability using dynamic Gd-DTPA scanning: a comparison of methods. Magn Reson Med 1992; 24:174-176.
26. Larsson HBW, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990; 16:117-131.
27. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging: 1. Fundamental concepts. Magn Reson Med 1991; 17:357-367.
28. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Parametrization of the MRI signal enhancement during and after i.v. infusion of Gd-DTPA: a pharmacokinetic model. In: Proceedings of the 9th annual meeting of the Society of Magnetic Resonance in Medicine. New York: Society of Magnetic Resonance in Medicine, 1990; 2:758.
29. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991; 15:621-628.
30. Kermode AG, Tofts PS. Non-invasive measurement of human blood-brain barrier transfer constant using dynamic magnetic resonance imaging. J Physiol 1990; 423:42P.
31. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984; 16:167-172.
32. Tofts PS, Berkowitz BA. Rapid measurement of capillary permeability using the early part of the dynamic Gd-DTPA MRI enhancement curve. J Magn Reson (part B) 1993; 102:129-136.
33. Berkowitz BA, Tofts PS, Sen HA, Ando N, de Juan E. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI. Invest Ophthalmol Vis Sci 1992; 33:3500-3506.
34. Berkowitz BA, Wilson CA, Tofts PS, Peshock RM. Effect of vitreous fluidity on the measurement of blood-retinal barrier permeability using contrast enhanced MRI. Magn Reson Med 1994; 31:61-66.
35. Tofts PS, Berkowitz B. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. Magn Reson Imaging 1994; 12:81-91.
36. Tofts PS, Berkowitz B, Schnall M. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumours using a permeability model. Magn Reson Med 1995; 33:564-568.
37. Furman-Haran E, Margalit R, Grobgeld D, Degani H. Dynamic contrast enhanced magnetic resonance imaging reveals stress induced angiogenesis in MCF7 human breast tumors. PNAS 1996; 93:6247-6251.
38. Tofts PS. Optimal detection of blood-brain barrier defects with Gd-DTPA: the influences of delayed imaging and optimised repetition time. Magn Reson Imaging 1996; 14:373-380.
39. Boas ML. Mathematical methods in the physical sciences. New York: Wiley, 1966.
40. Larsson HBW, Christiansen P, Stubgaard M, Thomsen C, Frederiksen J, Henriksen O. In vivo calculation of the unidirectional influx constant across the blood-brain barrier using MRI. In: Proceedings of the 9th annual meeting of the Society of Magnetic Resonance in Medicine. New York: Society of Magnetic Resonance in Medicine, 1990; 2:752.
41. Larsson HBW, Stubgaard M, Sondergaard L, Henriksen O. In vivo quantification of the unidirectional influx constant for Gd-diffusion across myocardial capillaries with MR imaging. J Magn Reson Imaging 1994; 4:433-440.
42. Larsson HBW, Fritz-Hansen T, Rostrup E, Sondergaard L, Ring P, Henriksen O. Myocardial perfusion modeling using MRI. Magn Reson Med 1996; 35:716-726.
43. Fritz-Hansen T, Rostrup E, Larsson HBW, Sondergaard L. Ring P, Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: a step towards quantitative perfusion imaging. Magn Reson Med 1996; 35:225-231.
44. Diesbourg LD, Prato FS, Wisenberg G, Drost DJ, Marshall TP, Carroll SE, O'Neill B. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischaemic tissue. Magn Reson Med 1992; 23:239-253.
45. Burstein D, Taratuta E, Manning WJ. Factors in myocardial "perfusion" imaging with ultrafast MRI and Gd-DTPA administration. Magn Reson Med 1991; 20:299-305.
46. Deleted in proof.
47. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995; 33:506-514.
48. Buckley DL, Kerslake RW, Blackband SJ, Horsman A. Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimisation procedure. Magn Reson Med 1994; 32:646-651.
49. Kuwatsuru R, Shames DM, Muhler A, et al. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn Reson Med 1993; 30:76-81.
50. Su M, Jao J, Nalcioglu O. Measurement of vascular volume fraction and blood-tissue permeability constants with a pharmacokinetic model: studies in rat muscle tumors with dynamic Gd-DTPA enhanced MRI. Magn Reson Med 1994; 32:714-724.
51. Gowland P, Mansfield P, Bullock P, Stehling M, Worthington B, Firth J. Dynamic studies of gadolinium uptake in brain tumors using inversion-recovery echo-planar imaging. Magn Reson Med 1992; 26:241-258.
52. Flickinger FW, Allison JD, Sherry RM, Wright JC. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Reson Imaging 1993; 11:617-620.
53. Heiberg EV, Perman WH, Herrmann VM, Janney CG. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn Reson Imaging 1996; 14:337-348.
54. Parker GJM, Tanner SF, Leach MO. Pitfalls in the measurement of tissue permeability over short time-scales using a low temporal resolution blood input function. In: Proceedings of the 4th annual scientific meeting of the International Society for Magnetic Resonance in Medicine. New York: International Society for Magnetic Resonance in Medicine, 1996; 3:1582.
55. Taylor NJ, Rowland IJ, Tanner SF, Leach MO. A rapid interleaved method for measuring signal intensity curves in both blood and tissue during contrast agent administration. Magn Reson Med 1993; 30:744-749.
56. 1H-NMR relaxation times and water compartmentalization in experimental tumor models. Magn Reson Imaging 1986; 4:335-342.
57. Donahue KM, Burstein D, Manning WJ, Gray ML. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994; 32:66-76.
58. Shuter B, Tofts PS, Wang SC, Pope JM. The relaxivity of Gd-EOB-DTPA and Gd-DTPA In liver and kidney of the Wistar rat. Magn Reson Imaging 1996; 14:243-253.
59. PS Tofts, B Shuter and JM Pope. Ni-DTPA doped agarose gel: a phantom material for Gd-DTPA enhancement measurements. Magn Reson Imaging 1993; 11:125-133.